comparemela.com

Latest Breaking News On - Luca issi - Page 7 : comparemela.com

CRSP Stock: FDA Considers Additional Review of CRISPR Therapeutics Gene Therapy

Although CRISPR Therapeutics may have a breakthrough drug on its hands, regulatory concerns hang over CRSP stock.

Morgan stanley terence flynnDrug administrationVertex pharmaceuticalsImplications awaitGene editingWall streetMorgan stanleyTerence flynnLuca issi

FDA staff focus on off-target risk in review of Vertex, CRISPR sickle cell therapy

BioPharma

Salim syedVertex pharmaceuticalsDrug administrationNobel prize winningLuca issiSecuritie salim syedGene therapy

NTLA Stock Stumbles As Intellia Aims For A First-Ever In CRISPR Gene Editing

NTLA Stock Stumbles As Intellia Aims For A First-Ever In CRISPR Gene Editing
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

United statesWedbush nierengartenMani forooharDavid nierengartenVertex pharmaceuticalsDrug administrationAlnylam pharmaceuticalsRegeneron pharmaceuticalsIntellia therapeuticsLuca issiCrispr therapeutics

Alnylam gives up on expanded use of heart-disease drug in US after FDA declines approval

Alnylam gives up on expanded use of heart-disease drug in US after FDA declines approval
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

United statesPooja desaiMyles minterWilliam blairDrug administrationThomson reuters trust principlesAlnylam pharmaceuticalsLuca issiMariam sunnyThomson reuters trust

FDA denies expanded approval for Alnylam RNA drug

BioPharma

Jeff poultonYvonne greenstreetAlnylam pharmaceuticalsDrug administrationLuca issi

vimarsana © 2020. All Rights Reserved.